The FDA has given approval to Sicel Technologies, out of Morrisville, North Carolina, to market company’s new generation of RFID radiation sensors for use during radiation therapy. The devices, which are 2 mm in diameter and 18 mm long, are injected into the tumor to send back readings to an external receiver via RFID. The new DVS-HFT dosimeter is capable of accurately measuring higher energy / shorter time radiation burst common in modern devices.
Here’s what the device can measure and transmit back:
the actual radiation dose hitting the tumor the uptake and retention of a particular chemotherapeutic agent the temperature during hyperthermia treatment the evaluation of combination therapies, monitoring the effects of chemotherapy and radiation therapy, both individually and together the level of parameters such as pH or oxygen
Press release: Sicel Technologies, Inc. Receives U.S. Food & Drug Administration Clearance for DVS®-HFT, a Next-Generation Wireless Sensor to Measure Actual Radiation Dose at Breast and Prostate Tumor Site…
Device page: Sicel DVS sensor
